-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
March 01, 2012 - Because the optimal duration
for therapy (and the role of monitoring in determining how
long to treat … And what patient factors are important
(such as the aforementioned low BMD at baseline)
in terms of determining
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_disposition-comments.pdf
April 28, 2015 - Public Reviewer
#1
Suzan Ulrich
General Determining the most effective treatment for postpartum … We
agree that determining the
underlying cause of a harm (the
PPH or the intervention) is
challenging
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
January 01, 2017 - Diagnosis and Management of Gout: Current State of the Evidence
Diagnosis and Management of Gout:
Current State of the Evidence
Focus of This Summary
This is a summary of two systematic reviews. One review evaluated the evidence regarding the accuracy and safety of tests
used to initially diagnose gout in the pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - similar
(e.g., anxiety, conduct disorders, speech or language delay, other developmental
disorders) and determining … collect the data required to
evaluate the study, as well as demographic and other data needed for determining … approach, comparator, and outcome) will be initially assessed
by one researcher with experience in determining … In determining the strength of a body of evidence, the following domains will be
evaluated:
• Study
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
January 01, 2024 - Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events
Evidence-based Practice Center Systematic Review Protocol
Project Title: Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid
and Cardiovascular Events
I. Background and Purpose of the Systematic Review…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_surveillance.pdf
January 01, 2013 - Findings and Conclusions ........................................................................ 2
2.6 Determining … withdrawal of a drug or surgical device from the market, a black box warning
from FDA, etc.
2.6 Determining
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
April 20, 2022 - A Systematic Review of Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features
Evidence-based Practice Center Systematic Review Protocol
Project Title: A Systematic Review of Postpa…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-afib.pdf
November 15, 2018 - to the EPC
program, although may be considered by EPCs along with other scientific research when
determining
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: January 10, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment
of Chronic Plaque Psoriasis …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
December 03, 2019 - Disposition of Comments for CER 222: Achieving Health Equity in Preventive Services
Comparative Effectiveness Review Disposition of Comments Report
Title: Achieving Health Equity in Preventive Services
Draft report available for public comment from June 19, 2019 to August 17, 2019.
Citation: Nelson HD, Cantor A…
-
effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - Major
bleeding following THR and TKR is estimated to be 1-3%.1 Determining the incidence of
major bleeding … In addition, factors identified in Table 6 are important when determining
applicability and will be
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - Major
bleeding following THR and TKR is estimated to be 1-3%.1 Determining the incidence of
major bleeding … In addition, factors identified in Table 6 are important when determining
applicability and will be
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
May 29, 2025 - Topic 0590 Strategies to Treat and Manage Infantile Hemangioma NSD FINAL_SJ
Strategies to Treat and Manage Infantile Hemangioma
Nomination Summary Document
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_executive.pdf
January 01, 2016 - But although a number of guidelines define
when antibiotic use is warranted, defining and determining … influenza, RSV); and routine diagnostic tests, such as chest x ray, and blood gases,
when used for determining
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Because of the multifaceted approach of Project Lazarus,
determining the impact of each individual
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - Table C-1. KQ 3,4, 5 Char.
Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (years) Eligible Minimum Age Actual Minimum Age …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Table C-1. KQ 3,4, 5 Char.
Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (Years) Eligible Minimum Age Actual Minimum Age …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
January 01, 2012 - to the EPC
Program, although may be considered by EPCs along with other scientific research when
determining … For individual-level decisions, values and preferences are key for determining the balance of
benefit … These choices, and therefore preferences, have an important
vi
role in determining how benefits … meet the goal.
34,35
Studies organize
these into a hierarchical decision model with the goal of determining … Operationally, we could define two criteria as being necessary for determining the best
treatment:
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - following a positive result from an initial noninvasive test is complex and there are many
nuances to determining … be
compared based on the moderate reproducibility of ICA, use of varying diagnostic thresholds for
determining … Recommendations Assessment, Development and
Evaluation) outlined in the AHRQ medical testing methods guide.18 In determining
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
April 01, 2015 - Determining when DMT is no
longer helpful is challenging. … Determining whether
rebound exists requires comparing disease activity
prior to receiving natalizumab … rare after the sixth decade of life and
very rare after the seventh decade), the problem arises of
determining